Mathers Edward T insider trades
Mathers Edward T has filed 54 Form 4s with the SEC that we hold, for OnKure Therapeutics, Inc. (OKUR) (Director), Rhythm Pharmaceuticals, INC. (RYTM) (Director), NEUE (Director, 10% owner) and Trevi Therapeutics, Inc. (TRVI) (Director), among 13 companies in all. Across all of them we count 5 purchases worth $27.3M and 3 sales worth $24.5K reported on Form 4. In the last 12 months: 2 purchases ($17.3M) and 0 sales ($0). The largest single trade was a purchase of 937,500 shares of SpyGlass Pharma, Inc. worth $15.0M, dated 2026-02-09. The first filing on our record is dated 2022-04-13 and the latest 2026-08-11.
OnKure Therapeutics, Inc. (OKUR)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Rhythm Pharmaceuticals, INC. (RYTM)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
NEUE
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-10-02 | S, sale reported on Form 4 | 280 | $1.9K | 2025-10-06 |
| 2025-10-02 | S, sale reported on Form 4 | 900 | $6.1K | 2025-10-06 |
| 2025-10-02 | S, sale reported on Form 4 | 2,455 | $16.6K | 2025-10-06 |
Trevi Therapeutics, Inc. (TRVI)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Senti Biosciences Holdings, Inc. (SNTI)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
MBX Biosciences, Inc. (MBX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-09-16 | P, purchase reported on Form 4 | 500,000 | $8.0M | 2024-09-17 |
INZY
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
AKUS
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Korro Bio, Inc. (KRRO)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-04-22 | P, purchase reported on Form 4 | 17,857 | $1,000.0K | 2024-04-24 |
| 2026-03-10 | P, purchase reported on Form 4 | 207,100 | $2.3M | 2026-03-12 |
Synlogic, INC. (SYBX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Mirum Pharmaceuticals, Inc. (MIRM)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Savara Inc (SVRA)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-07-17 | P, purchase reported on Form 4 | 333,333 | $1,000.0K | 2023-07-19 |
SpyGlass Pharma, Inc. (SGP)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-02-09 | P, purchase reported on Form 4 | 937,500 | $15.0M | 2026-02-11 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1328625) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms